Biocom

139 articles with Biocom

• Biocom California Strongly Opposes TRIPS Waiver

  5/7/2021

  Biocom CaliforniaBiocom CaliforniaBiocom CaliforniaBiocom California, the association representing the life science industry of California, issued the following statement in response to the White House’s support of a proposal to waive intellectual property rights for COVID-19 vaccines.

• Biocom California Appoints New Members to Board of Directors and Board of Governors

  2/18/2021

  Biocom California, the association representing the California life science industry, today announced that Enoch Kariuki, PharmD, chief financial officer of VelosBio, Bernard Parker, managing director of Caligen Bio, LLC, and Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics, have been added to its board of directors,

• Biocom California Supports Life Science Industry with New Return to Work Guide for 2021

  12/18/2020

  Guide presents solutions and strategies for life science companies to return to the workplace and lab safely, including vaccination and testing best practices

• Biocom Institute Launches Largest Diversity, Equity and Inclusion Report in California’s Life Science Industry

  12/17/2020

  Biocom Institute, a 501(c)(3) non-profit that supports life science innovation by strengthening the workforce and leaders of tomorrow, launched its first biennial report, “ Diversity, Equity and Inclusion in California’s Life Science Industry .” With more than 350 respondents, this report repre

• Biocom California Joins Legal Challenge to Department of Health and Human Services’ Most Favored Nation Interim Final Rule for Drug Pricing

  12/5/2020

  Biocom California, the association representing the California life science industry, joined the Biotechnology Innovation Organization and the California Life Sciences Association in filing a challenge against the Department of Health and Human Services’ recent Most-Favored Nation Interim Final Rule.

• Biocom California Stands Firm Against Most Favored Nation Rule

  11/21/2020

  Biocom California, the association representing the California life science industry, issued the following statement in response to the release of the Most Favored Nation Model by the Centers for Medicare and Medicaid Services.

• 

  BioSpace Movers & Shakers, Nov. 20

  11/20/2020

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

• Biocom California Appoints New Members to Board of Governors

  11/19/2020

  Biocom California, the association representing the California life science industry, announced that it has added Reza Halse, Ph.D., lead of Pacific BD&L Hub and president of Merck Research Laboratories Venture Fund;

• Biocom Purchasing Group Partners with Everlywell to Offer At-Home COVID-19 Testing and Lens Reporting Technology to Biocom Members

  10/27/2020

  Biocom Purchasing Group, a subsidiary of Biocom that accelerates life science success by leveraging innovative, member-driven strategic sourcing solutions that significantly lower the total cost of doing business, today announced a new program with Everlywell to offer at-home sample coll

• 

  BioSpace Movers & Shakers, Oct. 2

  10/2/2020

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

• Biocom Appoints Stephanie Hsieh as Executive Director of its Los Angeles Office

  9/28/2020

  Biocom, the association representing the life science industry of California, today announced the appointment of Stephanie Hsieh as the organization’s executive director for its Los Angeles office, effective immediately. “Steph is an accomplished biotech executive with deep industry knowledge t

• Biocom Purchasing Group Announces Randy Piper as Managing Director

  8/11/2020

  Biocom, the association representing the California life science industry, announced the appointment of Randy Piper as managing director for the Biocom Purchasing Group, a subsidiary of Biocom that accelerates life science success by leveraging innovative, member-driven strategic sourcing solutions that significantly lower the total cost of doing business.

• Leading State Life Sciences Associations Express Concerns with CMS’ Rule on Medicaid Value-Based Agreements

  7/20/2020

  BioNJ, Biocom, the California Life Sciences Association, the HINJ, LSPA, and the Michigan Biosciences Industry Association submitted comments to the CMS on a notice of proposed rulemaking impacting value-based purchasing agreements and other innovative solutions designed to provide patient access to, and purchasing agreements for, cutting edge therapies and cures.

• Biocom Supports California Life Science Companies with Best Practices Guide for Safely Returning to the Workplace

  5/29/2020

  Newly Available Publication Synthesizes Relevant Guidance from Multiple Federal and State Agencies

• AdvaMed and Biocom to Strategically Partner for The Digital MedTech Conference 2020

  2/10/2020

  Feb. 10, 2020 15:00 UTC The Digital MedTech Conference to showcase the growing and evolving digital medtech landscape WASHINGTON & SAN DIEGO--( BUSINESS WIRE )-- The Advanced Medical Technology Association (AdvaMed) and Biocom, the association representing the California life science industry, today announced a joint partnership to collaboratively produce The Digital MedTech Conference 2020. In combining Biocom’s DeviceFest and Digital Health Conference with AdvaMed’s D

• Biocom Condemns Passage of Innovation-Killing Drug Pricing Legislation

  12/12/2019

  Biocom, the association representing the life science industry of California, issued the following statement regarding the passage of H.R.3, the Lower Drug Costs Now Act, in the House of Representatives today

• Biocom Expresses Strong Concerns Over New USMCA Agreement Removing Essential Protections for Life-Saving Drugs

  12/11/2019

  Biocom, the association representing the life science industry of California, issued the following statement in response to the revised United States-Mexico-Canada Agreement deal unveiled yesterday by the Trump Administration.

• Biocom Appoints Karmin Noar as Executive Director of Biocom Institute

  12/4/2019

  In this role, she will oversee strategies, programs and staff and drive initiatives focused on STEM education and workforce development.

• New Data: Foreign Reference Pricing Proposal in H.R. 3 Would Slash Life-Saving R&D and Lead to Destruction of California’s Life Sciences Sector

  10/31/2019

  CLSA and Biocom Release Data Showing Anticipated Real-World Impact of Foreign Reference Pricing Proposed by House Democrats in H.R. 3 to Lower Drug Prices

• Biocom Announces Fourth Annual Catalyst Award Winners

  9/23/2019

  Biocom, the association representing the California life science industry, today announced the winners of its Fourth Annual Catalyst Awards